HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaodong Sun Selected Research

cytoplasmic linker protein 170 (restin)

4/2014Identification of a cytoplasmic linker protein as a potential target for neovascularization.
3/2014Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.
11/2013Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells.
4/2013Regulation of tumor angiogenesis by the microtubule-binding protein CLIP-170.
3/2012Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaodong Sun Research Topics

Disease

56Neoplasms (Cancer)
08/2022 - 04/2004
31Macular Degeneration (Age-Related Maculopathy)
05/2022 - 10/2012
19Inflammation (Inflammations)
01/2022 - 09/2004
18Retinal Detachment (Retinal Detachments)
10/2021 - 09/2007
16Carcinogenesis
08/2022 - 04/2003
16Choroidal Neovascularization
05/2022 - 09/2011
15Obesity
01/2022 - 02/2012
14Breast Neoplasms (Breast Cancer)
01/2020 - 02/2007
12Malaria
08/2022 - 09/2007
10Diabetic Retinopathy (Retinopathy, Diabetic)
07/2022 - 04/2009
10Prostatic Neoplasms (Prostate Cancer)
07/2015 - 04/2005
9Neoplasm Metastasis (Metastasis)
08/2022 - 05/2012
9Infections
03/2022 - 10/2010
8Glaucoma
01/2022 - 08/2014
7Macular Edema
01/2021 - 08/2012
7Hypoxia (Hypoxemia)
01/2021 - 04/2016
6Blindness (Hysterical Blindness)
01/2022 - 01/2015
6Polypoidal Choroidal Vasculopathy
01/2022 - 01/2015
5COVID-19
11/2022 - 01/2021
5Retinal Degeneration
01/2022 - 01/2017
5Myopia
01/2021 - 08/2015
5Fibrosis (Cirrhosis)
10/2020 - 09/2014
5Heart Failure
01/2019 - 03/2011
4Body Weight (Weight, Body)
02/2022 - 11/2012
4Non-alcoholic Fatty Liver Disease
01/2022 - 01/2020
4Insulin Resistance
01/2022 - 06/2011
4Epiretinal Membrane (Epiretinal Membranes)
01/2021 - 08/2015
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 11/2020
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 03/2015
4Myocardial Infarction
01/2020 - 09/2014
4Hemorrhage
01/2020 - 02/2016
4Ganglion Cysts (Ganglion)
01/2020 - 09/2007
4Cardiovascular Diseases (Cardiovascular Disease)
12/2019 - 04/2014
4Gliosis
12/2019 - 01/2008
4Lymphatic Metastasis
03/2018 - 08/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2017 - 10/2012
4Neovascular Glaucoma
02/2016 - 12/2015
3Pneumonia (Pneumonitis)
04/2022 - 06/2017
3Neuroinflammatory Diseases
01/2022 - 01/2021
3Retinal Vein Occlusion
01/2021 - 01/2013
3Cataract (Cataracts)
01/2021 - 07/2015
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 02/2015

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
08/2022 - 05/2005
27Retinaldehyde (Retinal)IBA
01/2022 - 09/2007
25Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 04/2009
14VaccinesIBA
11/2022 - 02/2012
13Messenger RNA (mRNA)IBA
12/2021 - 04/2005
13Transcription Factors (Transcription Factor)IBA
12/2021 - 04/2003
10Pharmaceutical PreparationsIBA
01/2022 - 09/2007
7LipidsIBA
01/2022 - 06/2011
7CytokinesIBA
10/2021 - 10/2010
6AdiponectinIBA
01/2022 - 10/2014
6RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
6DNA (Deoxyribonucleic Acid)IBA
09/2021 - 04/2008
6Bevacizumab (Avastin)FDA Link
02/2016 - 01/2011
5KH902 fusion proteinIBA
01/2022 - 01/2015
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 10/2010
5cytoplasmic linker protein 170 (restin)IBA
04/2014 - 03/2012
4CollagenIBA
08/2022 - 05/2010
4Cisplatin (Platino)FDA LinkGeneric
08/2022 - 02/2015
4empagliflozinIBA
01/2022 - 01/2020
4EnzymesIBA
01/2022 - 02/2009
4Therapeutic UsesIBA
01/2022 - 07/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 04/2009
4Peptides (Polypeptides)IBA
01/2022 - 11/2009
4Retinal Pigments (Pigments, Visual)IBA
11/2020 - 01/2018
4LigandsIBA
03/2020 - 04/2012
4Glucose (Dextrose)FDA LinkGeneric
01/2020 - 06/2011
4Ranibizumab (Lucentis)FDA Link
01/2020 - 08/2012
4artemisinin (artemisinine)IBA
02/2016 - 08/2012
4Fenofibrate (CiL)FDA LinkGeneric
10/2013 - 02/2012
4Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
04/2013 - 12/2005
4Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
01/2010 - 04/2003
3AntigensIBA
08/2022 - 01/2011
3AntibodiesIBA
08/2022 - 01/2011
3Carmustine (FIVB)FDA Link
01/2022 - 01/2020
3AntioxidantsIBA
01/2022 - 06/2011
3Amyloid (Amyloid Fibrils)IBA
01/2021 - 12/2018
3Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2021 - 06/2017
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 01/2019
3ResveratrolIBA
01/2021 - 11/2020
3Cadherins (E-Cadherin)IBA
01/2021 - 05/2012
3Silicone OilsIBA
01/2021 - 08/2018
3Biological ProductsIBA
12/2020 - 03/2019
3Nonesterified Fatty Acids (NEFA)IBA
12/2020 - 08/2013
3AlbuminsIBA
12/2020 - 01/2013
3LiraglutideFDA Link
12/2020 - 12/2019
31-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2020 - 06/2017

Therapy/Procedure

27Therapeutics
05/2022 - 02/2009
11Drug Therapy (Chemotherapy)
01/2022 - 03/2012
8Lasers (Laser)
01/2022 - 05/2012
8Aftercare (After-Treatment)
12/2021 - 04/2012
6Liver Transplantation
02/2022 - 03/2018
6Vitrectomy
01/2021 - 02/2013
5Radiotherapy
01/2022 - 02/2015
5Intravitreal Injections
01/2021 - 09/2007
5Transplantation
03/2018 - 05/2010
3Traction
01/2021 - 08/2015